iron chelation therapy

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2018
051020062018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Transfusional iron overload is a major target in the care of patients with transfusion-dependent thalassemia (TDT) and other… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2014
2014
BACKGROUND Most patients with myelodysplastic syndromes (MDS) require transfusions at the risk of iron overload and associated… (More)
Is this relevant?
2013
2013
Iron overload due to regular transfusions of packed red cells can cause multiple organ damage. Iron chelation therapy (ICT) is… (More)
Is this relevant?
2011
2011
BACKGROUND A patient with chemotherapy-resistant acute monocytic leukemia who achieved complete remission (CR) after iron… (More)
  • figure 1
  • figure 2
Is this relevant?
2010
2010
PURPOSE To understand how to appropriately recognize and manage iron overload with iron chelation therapy (ICT) in patients with… (More)
Is this relevant?
2009
2009
OBJECTIVES This study assesses satisfaction with iron chelation therapy (ICT) based on a reliable and valid instrument, and… (More)
Is this relevant?
2008
2008
INTRODUCTION This study of UK patients examines clinical, health-related quality of life (HRQOL) and economic outcomes associated… (More)
Is this relevant?
2008
2008
OBJECTIVE The primary objective of the study was to evaluate the cost-utility of deferasirox (Exjade) compared to standard… (More)
Is this relevant?
2007
2007
BACKGROUND Patients requiring chronic blood transfusions are at risk for iron overload, which, if not treated by iron chelation… (More)
Is this relevant?
2007
2007
BACKGROUND Iron chelation therapy (ICT) with deferoxamine (DFO), the current standard for the treatment of iron overload in… (More)
Is this relevant?